Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center

[1]  A. Ananthakrishnan,et al.  Effect of Accelerated Infliximab Induction on Short‐ and Long‐term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta‐analysis , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  M. Dubinsky,et al.  Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis. , 2018, Inflammatory bowel diseases.

[3]  J. Efron,et al.  Early Surgical Intervention for Acute Ulcerative Colitis Is Associated with Improved Postoperative Outcomes , 2017, Journal of Gastrointestinal Surgery.

[4]  A. Gorelik,et al.  Mo1878 Comparison of Accelerated Infliximab Induction vs Standard Induction Treatment in Acute Severe Ulcerative Colitis , 2016 .

[5]  A. Cheifetz,et al.  Surgery for Ulcerative Colitis Is Associated with a High Rate of Readmissions at 30 Days , 2015, Inflammatory bowel diseases.

[6]  C. Ponsioen,et al.  Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis. , 2015, Gastroenterology.

[7]  C. Redmond,et al.  An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  J. Marshall,et al.  Meta‐analysis: peri‐operative anti‐TNFα treatment and post‐operative complications in patients with inflammatory bowel disease , 2013, Alimentary pharmacology & therapeutics.

[9]  Fraser Cummings,et al.  The pattern and outcome of acute severe colitis. , 2010, Journal of Crohn's & colitis.

[10]  Zhiping Yang,et al.  Meta‐analysis: pre‐operative infliximab treatment and short‐term post‐operative complications in patients with ulcerative colitis , 2010, Alimentary pharmacology & therapeutics.

[11]  B. Sands.  Response to Letter by Field et al, Influenza Vaccinations: Should They Really be Encouraged for IBD Patients Being Treated with Immunosuppressives? , 2009 .

[12]  A. Griffiths,et al.  Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  Å. Danielsson,et al.  Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. , 2005, Gastroenterology.

[14]  L. Moldawer,et al.  Inhibition of tumor necrosis factor‐α attenuates wound breaking strength in rats , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.